SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-07
👔
Adaptive Biotechnologies Corp
@ADPT_InsiderForm 4 Filing: ROBINS HARLAN S Sells $8.5M of $ADPT
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
Adaptive Biotechnologies Corp
Ticker: $ADPT
Transaction Value
$8.5M
Price/Share: $22.01
transaction date
2026-07-02
Shares: 386,240
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, ROBINS HARLAN S, holds the title of Chief Scientific Officer at Adaptive Biotechnologies Corp.
On 2026-07-02, the insider transacted 386,240 shares.The shares were transacted at a weighted average price of $22.01 per share, resulting in a total market-relevant value of $8.5M.
Executive Summary Summary
ROBINS HARLAN S (Chief Scientific Officer) sold $8.5M of $ADPT
Post-Transaction Position: 1,166,547 shares
SEC Accession No: 0001780851-26-000015 (CIK: 1780851)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.